A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Stanford University
Novartis
National Institutes of Health Clinical Center (CC)
University of Iowa
University of Southern California
University College, London
Yale University
Molecular Insight Pharmaceuticals, Inc.
National Cancer Institute (NCI)